Price $30.43 |
Market Cap
2.74B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
13.8
|
P/B
2.61
|
P/S
0.43
|
Dividend %
3.70%
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-962.1K
|
FCF
-11.3
|
|
Op. Margin
3.60%
|
Net Margin
3.10%
|
ROE
19.20%
|
ROI
5.90%
|
|
ROA
7.10%
|
EPS Growth
23.90%
|
Current Ratio
1.7
|
Debt/Equity
46.90%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Societal CDMO Inc (SCTL) | $1.35 | - | - | 120.9M | Strong Buy |
| Cidara Therapeutics Inc (CDTX) | $1.21 | - | - | 54.1M | Strong Buy |
| Teva Pharmaceutical Industries (TEVA) | $10.38 | - | - | 10.35B | Strong Buy |
| Avalo Therapeutics Inc (AVTX) | $4.00 | - | - | 47.6M | Strong Buy |
| Clover Health Investments Corp (CLOV) | $1.25 | - | - | 443.2M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
